UNSPSC 51294208: Teniloxazine

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 95Q6WNP25P. European Medicines Agency schedules Teniloxazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10893MIG. Teniloxazine generally arises in the molecular formula C16H19NO2S.

UNSPSC 51294208 Teniloxane is a Commodity code that covers pharmaceutical products and related health-system supplies procured by state and local health agencies, community health programs, and multistate cooperative purchasing alliances. Recent state and local solicitations under this code reflect procurement of naloxone kits, generic pharmaceuticals, and over-the-counter products distributed through authorized wholesale channels to support public health initiatives, pharmacy benefit programs, and community health facilities. Issuing bodies include county health departments, state health and human services commissions, and regional cooperative purchasing entities that serve multiple jurisdictions. The work involves product specification, pricing negotiation, compliance with Drug Supply Chain Security Act (DSCSA) and current Good Manufacturing Practices (cGMP) standards, and delivery or distribution through authorized pharmaceutical wholesalers.

Recent activity appears concentrated in Florida and Minnesota, with multistate cooperative purchasing expanding the geographic reach. In June 2026, Seminole County, Florida released IFB 60459723LAS seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford, with a response deadline of July 26, 2023. The Texas Health and Human Services Commission posted Request for Information HHS0017013 in April 2026 to explore vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. Vendors must maintain relationships with authorized wholesalers including AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC, and carry commercial general liability insurance of $5,000,000 per occurrence.